BOSTON, MA (October 7, 2022) — Valo Health, Inc (“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, announced that David Berry, founder & CEO of Valo will deliver the keynote address at the Founders Network’s fnSummit 2022 where he will share his insights on what it takes to be a serial entrepreneur.
“When you want to do something without precedent, you have to have that will and that conviction. It’s about taking what you want and making it so. But I firmly believe that is what we all signed up for and we have the opportunity to live the vision we are trying to create.“ — David Berry, founder & CEO, Valo Health
About Valo Health
Valo Health, Inc (“Valo”) is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, New York, NY, Branford, CT, and San Francisco, CA. To learn more, visit www.valohealth.com.